Last reviewed · How we verify
MBF-118 oral capsules
At a glance
| Generic name | MBF-118 oral capsules |
|---|---|
| Sponsor | Medibiofarma S.L. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Safety and Efficacy of MBF-118 in Patients with Crohn Disease (PHASE2)
- Study to Assess the Safety and Tolerability of MBF-118 in Healthy Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- MBF-118 oral capsules CI brief — competitive landscape report
- MBF-118 oral capsules updates RSS · CI watch RSS
- Medibiofarma S.L. portfolio CI